Cannabinoids, Neural Synchrony, and Information Processing

• Status: Active, not recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The study examines the effects of delta-9-tetrahydrocannabinol (Δ9-THC), the principal active ingredient of cannabis, on neural synchrony. Neural synchrony is studied using electroencephalography (EEG).

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Yale University
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Ethanol

Criteria

Inclusion Criteria:

• Men and women aged 18 and 55 years (extremes included) on the day of the first dosing.

• Exposed to cannabis at least once.

Exclusion Criteria:

1. Cannabis naïve

2. Positive pregnancy screen during screening

3. Hearing deficits